CR20220079A - Formas sólidas de n-ter-butil-4[[2-(5-cloro-2-hidroxi-fenil)acetil]amino]piridin-2-carboxamida - Google Patents
Formas sólidas de n-ter-butil-4[[2-(5-cloro-2-hidroxi-fenil)acetil]amino]piridin-2-carboxamidaInfo
- Publication number
- CR20220079A CR20220079A CR20220079A CR20220079A CR20220079A CR 20220079 A CR20220079 A CR 20220079A CR 20220079 A CR20220079 A CR 20220079A CR 20220079 A CR20220079 A CR 20220079A CR 20220079 A CR20220079 A CR 20220079A
- Authority
- CR
- Costa Rica
- Prior art keywords
- carboxamide
- acetyl
- pyridine
- chloro
- tert
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1910664.0A GB201910664D0 (en) | 2019-07-25 | 2019-07-25 | Novel forms of compound |
| PCT/GB2020/051779 WO2021014167A1 (en) | 2019-07-25 | 2020-07-24 | Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phneyl)acetyl]amino]pyridine-2-carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20220079A true CR20220079A (es) | 2022-06-28 |
Family
ID=67990591
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20220079A CR20220079A (es) | 2019-07-25 | 2020-07-24 | Formas sólidas de n-ter-butil-4[[2-(5-cloro-2-hidroxi-fenil)acetil]amino]piridin-2-carboxamida |
| CR20250316A CR20250316A (es) | 2019-07-25 | 2020-07-24 | Formas sólidas de n-ter-butil-4[[2-(5-cloro-2-hidroxi- fenil)acetil]amino]piridin-2-carboxamida (divisional exp. 2022-0079) |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20250316A CR20250316A (es) | 2019-07-25 | 2020-07-24 | Formas sólidas de n-ter-butil-4[[2-(5-cloro-2-hidroxi- fenil)acetil]amino]piridin-2-carboxamida (divisional exp. 2022-0079) |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US12281077B2 (https=) |
| EP (1) | EP4003960A1 (https=) |
| JP (1) | JP7627683B2 (https=) |
| KR (1) | KR20220087430A (https=) |
| CN (1) | CN114585607B (https=) |
| AU (1) | AU2020318943A1 (https=) |
| BR (1) | BR112022001276A2 (https=) |
| CA (1) | CA3145285A1 (https=) |
| CL (1) | CL2022000187A1 (https=) |
| CO (1) | CO2022002046A2 (https=) |
| CR (2) | CR20220079A (https=) |
| GB (1) | GB201910664D0 (https=) |
| IL (1) | IL290071B1 (https=) |
| MX (1) | MX2022000891A (https=) |
| MY (1) | MY207877A (https=) |
| PE (1) | PE20221407A1 (https=) |
| PH (1) | PH12022550193A1 (https=) |
| UA (1) | UA129300C2 (https=) |
| WO (1) | WO2021014167A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050176767A1 (en) * | 2003-10-30 | 2005-08-11 | Laval Chan Chun Kong | Pyridine carboxamide and methods for inhibiting HIV integrase |
| CA2658362A1 (en) | 2006-06-29 | 2008-01-03 | Alantos Pharmaceuticals Holding, Inc. | Metalloprotease inhibitors |
| WO2016042114A1 (en) * | 2014-09-19 | 2016-03-24 | F. Hoffmann-La Roche Ag | Cxcl14 as a biomarker of hedgehog pathway activity for the diagnosis, prognosis and treatment of idiopathic pulmonary fibrosis |
| US11358947B2 (en) | 2017-04-17 | 2022-06-14 | The Regents Of The University Of California | Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel TMEM16A |
| GB201801355D0 (en) * | 2018-01-26 | 2018-03-14 | Enterprise Therapeutics Ltd | Compounds |
-
2019
- 2019-07-25 GB GBGB1910664.0A patent/GB201910664D0/en not_active Ceased
-
2020
- 2020-07-24 MY MYPI2022000419A patent/MY207877A/en unknown
- 2020-07-24 WO PCT/GB2020/051779 patent/WO2021014167A1/en not_active Ceased
- 2020-07-24 CN CN202080053826.8A patent/CN114585607B/zh active Active
- 2020-07-24 PE PE2022000136A patent/PE20221407A1/es unknown
- 2020-07-24 PH PH1/2022/550193A patent/PH12022550193A1/en unknown
- 2020-07-24 JP JP2022505329A patent/JP7627683B2/ja active Active
- 2020-07-24 AU AU2020318943A patent/AU2020318943A1/en active Pending
- 2020-07-24 KR KR1020227006247A patent/KR20220087430A/ko active Pending
- 2020-07-24 EP EP20751235.1A patent/EP4003960A1/en active Pending
- 2020-07-24 IL IL290071A patent/IL290071B1/en unknown
- 2020-07-24 MX MX2022000891A patent/MX2022000891A/es unknown
- 2020-07-24 CA CA3145285A patent/CA3145285A1/en active Pending
- 2020-07-24 CR CR20220079A patent/CR20220079A/es unknown
- 2020-07-24 UA UAA202200857A patent/UA129300C2/uk unknown
- 2020-07-24 CR CR20250316A patent/CR20250316A/es unknown
- 2020-07-24 BR BR112022001276A patent/BR112022001276A2/pt unknown
-
2022
- 2022-01-24 CL CL2022000187A patent/CL2022000187A1/es unknown
- 2022-01-24 US US17/582,539 patent/US12281077B2/en active Active
- 2022-02-25 CO CONC2022/0002046A patent/CO2022002046A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3145285A1 (en) | 2021-01-28 |
| GB201910664D0 (en) | 2019-09-11 |
| IL290071B1 (en) | 2026-02-01 |
| AU2020318943A1 (en) | 2022-03-17 |
| JP2022542918A (ja) | 2022-10-07 |
| BR112022001276A2 (pt) | 2022-03-22 |
| JP7627683B2 (ja) | 2025-02-06 |
| KR20220087430A (ko) | 2022-06-24 |
| PH12022550193A1 (en) | 2023-01-09 |
| MX2022000891A (es) | 2022-05-26 |
| EP4003960A1 (en) | 2022-06-01 |
| US20220220074A1 (en) | 2022-07-14 |
| US12281077B2 (en) | 2025-04-22 |
| CN114585607B (zh) | 2025-11-14 |
| CL2022000187A1 (es) | 2022-10-07 |
| CO2022002046A2 (es) | 2022-06-10 |
| CR20250316A (es) | 2025-08-27 |
| UA129300C2 (uk) | 2025-03-12 |
| CN114585607A (zh) | 2022-06-03 |
| IL290071A (en) | 2022-03-01 |
| WO2021014167A1 (en) | 2021-01-28 |
| PE20221407A1 (es) | 2022-09-20 |
| MY207877A (en) | 2025-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021008002A (es) | Sales nuevas y forma polimorfica del acido bempedoico. | |
| EP4480483A3 (en) | Solid state forms of belumosudil and belumosudil salts | |
| GB202101909D0 (en) | Novel crystalline form of pyroxa-sulfone, methods for its preparation and use of the same | |
| EP3986870A4 (en) | NEW CRYSTALLINE FORM OF OLAPARIB AND PROCESS OF PRODUCTION | |
| CA3139411A1 (en) | Novel peptide compound or pharmaceutically acceptable salt thereof | |
| EP4480538A3 (en) | Solid state forms of mavacamten and process for preparation thereof | |
| MX2021003862A (es) | Formas cristalinas y procesos de besilato de lenvatinib. | |
| MY198008A (en) | Crystal of benzofuran derivative free base and preparation method | |
| SG11202108863WA (en) | Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof | |
| MX2021001904A (es) | Formas solidas de benzoxaborol sustituido y composiciones de las mismas. | |
| EP4353230A3 (en) | Solid state forms of asciminib and process for preparation thereof | |
| PH12021550456A1 (en) | Crystalline forms of a quinazole compound and its hydrochloride salts | |
| TW200640886A (en) | Crystalline forms of linezolid intermediate | |
| ZA202205170B (en) | Process and intermediate for the preparation of oxetan-2-ylmethanamine | |
| PH12022550193A1 (en) | Solid forms of n-tert-butyl-4[[2-(5-chloro-2-hydroxy-phneyl)acetyl]amino]pyridine-2-carboxamide | |
| ZA200800138B (en) | Process for the preparation of crystalline perindopril | |
| MX2024003904A (es) | Formas cristalinas de moduladores de los canales de potasio. | |
| WO2021107522A3 (ko) | 알룰로스 제조용 조성물 및 이를 이용한 알룰로스의 제조 방법 | |
| AU2024290368A1 (en) | Crystalline form | |
| WO2014195977A3 (en) | Novel polymorphs of vismodegib | |
| MX2023008883A (es) | Polimorfo de diclorhidrato de latrepirdina. | |
| PH12020500385A1 (en) | A process for preparation of triaminopyrimidine compound and intermediates thereof | |
| AU2019248350A8 (en) | Process for making sarecycline hydrochloride | |
| MX2021012690A (es) | Formas cristalinas y metodos para producir formas cristalinas de un compuesto. | |
| WO2020055360A3 (en) | The parenteral composition comprising carfilzomib |